Delivery Order SPE2DE24D0013-SPE2D626F64V4
- Not listed
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $10,200.00 by the Defense Logistics Agency Medical Supply Chain on December 10, 2025. The firm fixed-price delivery order, with an ultimate completion date of December 17, 2025, is designated as XPRS4PLEX-10 and carries no set-aside designation. This delivery order falls under Cepheid's broader contracting relationship with federal healthcare agencies, where...
- Cepheid Inc., a Sunnyvale, California-based molecular diagnostics manufacturer, has been awarded a firm fixed-price delivery order valued at $5,645.08 by the Defense Logistics Agency Medical Supply Chain (a Department of Defense entity). The delivery order, designated XPRSMVP-10 with an ultimate completion date of November 25, 2025, carries no small business set-aside designation. This award represents a continuation of Cepheid's established role as a primary federal supplier of diagnostic...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a firm fixed-price delivery order valued at $9,216.80 by the Defense Logistics Agency Medical Supply Chain on December 10, 2025, with an ultimate completion date of December 17, 2025. This delivery order, designated XPRSMVP-10 (Contract Number 4570254413), represents a continuation of the federal government's reliance on Cepheid's diagnostic capabilities. The contract utilizes no...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $27,650.40 by the Defense Logistics Agency Medical Supply Chain on November 13, 2025. This firm fixed-price delivery order, designated XPRSMVP-10 with completion targeted for November 20, 2025, represents a procurement of diagnostic testing supplies and reagents under an existing indefinite delivery contract vehicle. The award carries no set-aside designation,...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a firm fixed-price delivery order valued at $1,968.80 by the Defense Logistics Agency's Medical Supply Chain on April 23, 2025, with an ultimate completion date of May 7, 2025. This delivery order, which carries no set-aside designation, represents a continuation of Cepheid's ongoing provision of diagnostic equipment and testing solutions to federal healthcare systems. The contract is likely...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $38,461.80 under a firm fixed-price contract by the Defense Logistics Agency's Medical Supply Chain on December 22, 2025. The delivery order, designated XPRSMVP-10, is scheduled for completion by January 7, 2026, and carries no set-aside designation. This award represents a continuation of Cepheid's established role as a primary federal supplier of...
- Cepheid Inc., headquartered in Sunnyvale, California, has been awarded a delivery order valued at $1,597.30 under a Defense Logistics Agency Medical Supply Chain contract (4570223169). This firm fixed-price delivery order, issued on December 9, 2025, with an ultimate completion date of December 16, 2025, represents a continuation of Cepheid's established role as a primary federal supplier of molecular diagnostic solutions. The contract carries no set-aside designation, reflecting Cepheid's...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $15,547.60 by the Defense Logistics Agency Medical Supply Chain on December 23, 2025. This firm fixed-price delivery order, designated XPRSMVP-10 with a completion date of December 31, 2025, represents a continuation of Cepheid's established role as a primary federal supplier of diagnostic solutions. The award carries no set-aside designation, reflecting...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $2,039.40 by the Defense Logistics Agency's Medical Supply Chain on October 22, 2025, with a completion deadline of November 5, 2025. This firm fixed-price delivery order carries no set-aside designation and represents work to be performed at the contractor's Sunnyvale location. The award falls under the Defense Logistics Agency's procurement operations, which...
- Cepheid Inc., a Sunnyvale, California-based molecular diagnostics manufacturer, was awarded a delivery order valued at $2,765.04 on December 16, 2025, under the Defense Logistics Agency Medical Supply Chain contract vehicle. This firm fixed-price delivery order, designated XPRSMVP-10, is scheduled for completion by December 23, 2025, and will be performed at Cepheid's Sunnyvale facility. The award includes no small business set-aside designation, reflecting Cepheid's established competitive...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F64V4Delivery Order
Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $6,550 by the Defense Logistics Agency Medical Supply Chain on December 30, 2025, with an ultimate completion date of January 14, 2026. This firm fixed-price delivery order, which carries no set-aside designation, represents a small procurement for diagnostic testing supplies and reagents consistent with Cepheid's extensive federal contracting history. The award leverages Cepheid's established capabilities in molecular diagnostics, particularly its GeneXpert diagnostic platform, which the company has supplied to multiple federal healthcare agencies including the Department of Veterans Affairs, Indian Health Service, Defense Health Agency, and U.S. Coast Guard. This delivery order operates within the context of Cepheid's substantial federal presence, most notably through two significant Indefinite Delivery Contracts with the Department of Veterans Affairs: a $6.7 million IDC with VISN 17 extending through December 2029 and a $32.8 million IDC with VISN 6 extending through September 2030. These framework agreements have generated numerous delivery orders supporting the VA's clinical laboratory operations and infectious disease testing requirements across its distributed network of medical centers. Cepheid's continued procurement across federal agencies underscores its role as a primary supplier of molecular diagnostic solutions for detecting infectious diseases including COVID-19, influenza, tuberculosis, and other clinical conditions critical to federal healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.6k | 12/29/25 |